The Patent Finder

Maintenance fees coming due

Immedica Pharma US Inc.

6 maintenance fees come due in the 12 months from Nov 18, 2026, the next on Dec 20, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,679,117Ganaxolone for Use in Treatment of Status Epilepticus
In force
Fee due Dec 20, 2026
Lapses if unpaid Jun 21, 2027
 · Medium confidence
Immedica Pharma US Inc.In forceDec 20, 2026Jun 21, 2027Medium confidence
US 11,701,367Ganaxolone for Use in Treating Tuberous Sclerosis Complex
In force
Fee due Jan 18, 2027
Lapses if unpaid Jul 19, 2027
 · Medium confidence
Immedica Pharma US Inc.In forceJan 18, 2027Jul 19, 2027Medium confidence
US 11,717,562Method and Composition for Treating Arginase 1 Deficiency
In force
Fee due Feb 8, 2027
Lapses if unpaid Aug 9, 2027
 · High confidence
Immedica Pharma ABIn forceFeb 8, 2027Aug 9, 2027High confidence
US 10,391,105Methods of Treating Certain Depressive Disorders and Delirium Tremens
In force
Fee due Feb 27, 2027
Lapses if unpaid Aug 27, 2027
 · High confidence
Immedica Pharma US Inc.In forceFeb 27, 2027Aug 27, 2027High confidence
US 10,639,317Methods of Treating Certain Depressive Disorders and Delirium Tremens
In force
Fee due Nov 5, 2027
Lapses if unpaid May 5, 2028
 · High confidence
Immedica Pharma US Inc.In forceNov 5, 2027May 5, 2028High confidence
US 11,980,625Ganaxolone for Use in Treating Tuberous Sclerosis Complex
In force
Fee due Nov 14, 2027
Lapses if unpaid May 15, 2028
 · Medium confidence
Immedica Pharma US Inc.In forceNov 14, 2027May 15, 2028Medium confidence
6 of 6 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited